The Prevalence of Sarcopenia in a Cohort of Haemodialysis Patients and Its Correlation With Mortality

The study aims to explore the correlation between the prevalence of sarcopenia and one year mortality amongst patients on maintenance hemodialysis

Completed

Looking for future studies?

Notify Me

Key information

Conditions

End-stage Kidney Disease Atrophy Chronic Disease Dialysis Dependent Chronic Kidney Disease Disease Attributes End-stage Renal Disease Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Muscular Atrophy Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathologic Processes Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Sarcopenia Signs and Symptoms Urogenital Diseases Urologic Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kasr Alainy University Hospitals

Cairo, Egypt

About this study

In our study , we aim to explore the correlation between the prevalence of sarcopenia and one year mortality among patients on maintenance hemodialysis The lean muscle mass was measured using bio-impedance analysis (BIA ). The hand-grip test was used to measure the function .

Sarcopenia was defined using European Working Group on Sarcopenia in Older people (EWGSOP) definition which involves reduced muscle function and reduced muscle mass

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with End stage kidney disease on maintenance dialysis

Exclusion criteria

unable to consent or terminal malignancy

Treatment and study plan

Hand grip function testing

Diagnostic Test

The use of Bio-impedance to measure the skeletal muscle mass

Other names: Measuring skeletal body mass using bio-impedance analysis ( BIA)

Primary outcomes

One year mortality

Time frame: One year

All cause mortality of patients with end stage kidney disease on hemodialysis

Sponsors and collaborators

Lead sponsor

Kasr El Aini Hospital

Other

Registry information

Official study title

The Prevalence of Sarcopenia in a Cohort of Patients With End Stage Kidney Disease on Haemodialysis Patients and Its Correlation With Mortality

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2023
First posted: Jun 27, 2024
Registry last updated: Jun 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed